Tolerability and Efficacy of INSTYLAN in Subjects With Moderate to Severe Hemorrhagic Cystitis
Not Applicable
- Conditions
- Hemorrhagic Cystitis
- Interventions
- Device: INSTYLAN (Sodium Hyaluronate 80mg/50ml)
- First Posted Date
- 2021-01-06
- Last Posted Date
- 2021-01-06
- Lead Sponsor
- LIDDE Therapeutics
- Target Recruit Count
- 30
- Registration Number
- NCT04696666
- Locations
- 🇫🇷
Aix en Provence Hospital Center, Aix-en-Provence, France
🇫🇷Ajaccio Hospital Center (Notre Dame de la Miséricorde), Ajaccio, France
🇫🇷Clinic Rhône Durance (Avignon), Avignon, France
© Copyright 2025. All Rights Reserved by MedPath